IRIDEX Corp (NAS:IRIX)
$ 2.45 -0.04 (-1.61%) Market Cap: 39.82 Mil Enterprise Value: 37.57 Mil PE Ratio: 0 PB Ratio: 6.13 GF Score: 64/100

IRIDEX Corp at ROTH Conference Transcript

Mar 19, 2019 / 04:00PM GMT
Release Date Price: $4.45 (+0.45%)
Unidentified Analyst

Okay, we are going to move on to our next presentation from IRIDEX Corporation, ticker IRIX. An approximately $65 million market cap medical device company focused on ocular indications.

Presenting for the Company is George Marcellino, Vice President of Medical Affairs. Take it away, George, and thank you for coming.

George Marcellino
IRIDEX Corporation - VP, Clinical Affairs

Thank you very much. Very good; thank you very much for coming today. Will Moore, our CEO, was unable to attend and so he asked me to stand in for him. It's certainly a pleasure to be here today addressing you.

And I thought I might just start off with a brief bio because it's doubtful that any of you who know I am. So I have -- I will keep it germane to this industry, but I've been in the medical device industry for 40 years. And 30 of that has been in the application of lasers for both medicine and surgery and most of that has been for ophthalmology.

So I spent 15 years at Coherent, and highlights of that time were the introduction of selective

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot